Literature DB >> 27407806

IgM Chlamydia Trachomatis Antibodies in Cases of Melasma.

Mps Sawhney1, R B Batra2.   

Abstract

BACKGROUND: Melasma is an acquired photosensitive hypermelanosis in sun-exposed areas, especially seen in females. The exact cause of this disorder is not known. Association of melasma with chronic pelvic inflammatory disease (PID) has been described earlier. Chlamydia trachomatis is an important etilogical agent in acute and chronic PID and photosensitivity has been described in almost 50% cases of chronic lymphogranuloma venereum caused by 1.1, 1.2 and 13 serovars of C. trachomatis.
METHOD: Blood of 38 cases of melasma in women and 31 healthy females was tested for the presence of C. trachomatis IgM antibodies by ELISA.
RESULTS: The average age of the patients was 35.6(range 19-51) years and that of controls was 38(range 24-55). 7(18.42%) and 5 (13.16%) of the patients of melasma were positive and borderline positive for IgM antibodies respectively. None of the healthy controls were positive. The difference was statistically significant.
CONCLUSION: Melasma in women is most likely due to photosensitivity to C.trachomatis in cases of chronic pelvic inflammatory disease.

Entities:  

Keywords:  Chlamydia trachomatis infection; Melasma

Year:  2011        PMID: 27407806      PMCID: PMC4922924          DOI: 10.1016/S0377-1237(05)80063-2

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  14 in total

1.  Chronic pelvic inflammatory disease and melasma in women.

Authors:  M Sawhney; R Anand
Journal:  Indian J Dermatol Venereol Leprol       Date:  2003 May-Jun       Impact factor: 2.545

Review 2.  Melasma. Etiologic and therapeutic considerations.

Authors:  P E Grimes
Journal:  Arch Dermatol       Date:  1995-12

Review 3.  Dermatoses of pregnancy.

Authors:  G B Winton; C W Lewis
Journal:  J Am Acad Dermatol       Date:  1982-06       Impact factor: 11.527

4.  The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis.

Authors:  S Bas; T Cunningham; T K Kvien; A Glennås; K Melby; T L Vischer
Journal:  Br J Rheumatol       Date:  1996-06

5.  Synovial fluid and serum antibodies against Chlamydia in different forms of arthritis: intra-articular IgA production in Chlamydia sexually acquired reactive arthritis.

Authors:  S Bas; T Cunningham; T K Kvien; A Glennås; K Melby; T L Vischer
Journal:  Br J Rheumatol       Date:  1996-06

6.  Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis.

Authors:  S Bas; T L Vischer
Journal:  Br J Rheumatol       Date:  1998-10

7.  Usefulness of retinoic acid in the treatment of melasma.

Authors:  M A Pathak; T B Fitzpatrick; E W Kraus
Journal:  J Am Acad Dermatol       Date:  1986-10       Impact factor: 11.527

8.  Endocrinologic profile of patients with idiopathic melasma.

Authors:  M Pérez; J L Sánchez; F Aguiló
Journal:  J Invest Dermatol       Date:  1983-12       Impact factor: 8.551

9.  Skin manifestations associated with tumours of the brain.

Authors:  V C Adreev; I Petkov
Journal:  Br J Dermatol       Date:  1975-06       Impact factor: 9.302

10.  Chloasma, oral contraceptives, and plasma immunoreactive beta-melanocyte-stimulating hormone.

Authors:  A G Smith; S Shuster; A J Thody; M Peberdy
Journal:  J Invest Dermatol       Date:  1977-04       Impact factor: 8.551

View more
  1 in total

1.  Chlamydia trachomatis Infection and Photosensitive Dermatoses.

Authors:  Mps Sawhney; S Arora; A Khetrapal
Journal:  Med J Armed Forces India       Date:  2011-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.